newsfilter
← Latest News
Business Wire·

Appili Therapeutics Inc. Expands PRESECO Clinical Trial of Avigan®/Reeqonus™ for Mild-to-Moderate COVID-19 Patients into Mexico and Brazil

Appili Also Provides Additional Trial Updates Appili Therapeutics Inc. (TSX:APLI) (OTCQX:APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases, has added several clinical research sites in